Source:http://linkedlifedata.com/resource/pubmed/id/17174555
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
2007-3-2
|
pubmed:abstractText |
Sporadic Alzheimer's disease (AD) is the most frequent form of dementia in the elderly. A non-conservative polymorphism in the urokinase-type plasminogen activator gene (PLAU_1=RS2227564) has been analyzed, but data are conflicting on whether it is a risk factor for AD. To clarify whether this genetic variant modifies AD risk in the Italian population, we ran a case-control association study on 192 AD and 126 age-matched controls. We did not find any association between PLAU_1 genotype and AD in the whole AD population, but when we stratified our sample by APOE-epsilon4 status, we found a significant association between PLAU_1 genotype (C/T+T/T) and APOE-epsilon4 negative AD subjects (p=0.02, chi(2)-test). The PLAU_1 genotype did not appear to affect the plasma Abeta42 concentration. Our data support a role for PLAU_1 as an independent genetic risk factor for AD in the Italian population for those subjects who do not have the APOE-epsilon4 allele.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Amyloid beta-Peptides,
http://linkedlifedata.com/resource/pubmed/chemical/Apolipoprotein E4,
http://linkedlifedata.com/resource/pubmed/chemical/Peptide Fragments,
http://linkedlifedata.com/resource/pubmed/chemical/Urokinase-Type Plasminogen Activator,
http://linkedlifedata.com/resource/pubmed/chemical/amyloid beta-protein (1-42)
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0969-9961
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
25
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
609-13
|
pubmed:dateRevised |
2010-11-18
|
pubmed:meshHeading |
pubmed-meshheading:17174555-Aged,
pubmed-meshheading:17174555-Alzheimer Disease,
pubmed-meshheading:17174555-Amyloid beta-Peptides,
pubmed-meshheading:17174555-Apolipoprotein E4,
pubmed-meshheading:17174555-Case-Control Studies,
pubmed-meshheading:17174555-Genetic Predisposition to Disease,
pubmed-meshheading:17174555-Genotype,
pubmed-meshheading:17174555-Humans,
pubmed-meshheading:17174555-Italy,
pubmed-meshheading:17174555-Middle Aged,
pubmed-meshheading:17174555-Peptide Fragments,
pubmed-meshheading:17174555-Polymorphism, Genetic,
pubmed-meshheading:17174555-Risk Factors,
pubmed-meshheading:17174555-Urokinase-Type Plasminogen Activator
|
pubmed:year |
2007
|
pubmed:articleTitle |
The urokinase-type plasminogen activator polymorphism PLAU_1 is a risk factor for APOE-epsilon4 non-carriers in the Italian Alzheimer's disease population and does not affect the plasma Abeta(1-42) level.
|
pubmed:affiliation |
Department of Neuroscience, Mario Negri Institute for Pharmacological Research, via Eritrea 62, 20157 Milan, Italy.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|